Alcoholic Liver Disease (ALD)
At a Glance
No biochemical markers pathognomonic for alcoholic liver disease (ALD) exist. The diagnosis has to start with evidence of alcohol abuse either from a history of documented blood alcohol levels or from response to one of the questionnaires desired to elicit a history of ongoing alcohol abuse.
What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?
Historically, gamma glutamyl transpeptidase (GGT) has been used as a screening tool for alcoholism.
Another, relatively specific marker for ALD is carbohydrate deficient transferrin (CDT).
Elevations of aspartate aminotransferase up to six times the upper limit of normal and alanine aminotransferase up to 5 times its upper limit of normal is consistent with alcohol abuse, especially with a ratio greater than 2:1. A ratio of 3:1 has a sensitivity of 90% for the diagnosis.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Pediatric Outpatient Antimicrobial Stewardship: Minimizing Antibiotic Duration
- Better Detection and Treatment Needed for H pylori Infections in Children
- Are Antibiotic Stewardship Programs the Antidote to Antibiotic Overuse?
- FDA Approves New Hepatitis B Vaccine for Adults
- Strategies for Preventing Antibiotic Resistance in Acne
- Dual Regimen Provides Simple and Safe Salvage Therapy in HIV-1
- Effectiveness of Ledipasvir/Sofosbuvir for Acute HCV Infection in HIV
- Diclofenac Inferior to Norfloxacin for UTI Symptom Relief
- Legionella Linked to Most Drinking Water-Associated Outbreaks
- Preventing HCV Transmission: Utility of Needle/Syringe Programs